A Novel Topical PPAR 3 Agonist Induces PPAR 3 Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
Background Peroxisome proliferator-activated receptor-gamma (PPAR 3) exerts anti-inflammatory effects and is therefore a potential target in ulcerative colitis (UC). A novel PPAR 3 agonist (AS002) developed for local action was evaluated ex vivo in biopsies from UC patients and in vivo in mice with low-grade dextran sodium sulfate (DSS)- and trinitrobenzene sulfonic acid (TNBS)-induced colitis. Me
